Atlas Trials

A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder

Clinical trial NCT02476058 · COMPLETED

Trial details

NCT number
NCT02476058
Sponsor
Janssen-Cilag International NV
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2015-06-11
Primary completion
2016-01-04
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.